These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17976107)

  • 21. Dual-chamber implantable cardioverter defibrillator implantation guided by non-fluoroscopic electro-anatomical navigation.
    Merino JL; Peinado R; Silvestre J
    Europace; 2008 Sep; 10(9):1124-5. PubMed ID: 18606618
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epicardial implantation of a transvenous implantable cardioverter-defibrillator system in Ebstein's malformation with tricuspid valve repair.
    Peng E; Murray S; Lowrey M; Hasan A
    J Cardiol Cases; 2015 Sep; 12(3):91-93. PubMed ID: 30524547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biventricular implantable cardioverter defibrillator right ventricle pace-sense ring electrode failure: lead switch fix.
    Venkataraman G; Moore H; Karasik P; Singh S; Fletcher R
    Pacing Clin Electrophysiol; 2008 Jul; 31(7):899-903. PubMed ID: 18684289
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nontransvenous implantable cardioverter defibrillator systems: not just for small pediatric patients.
    Kugler JD; Erickson CC
    J Cardiovasc Electrophysiol; 2006 Jan; 17(1):47-8. PubMed ID: 16426399
    [No Abstract]   [Full Text] [Related]  

  • 25. [Placement of an implantable defibrillator via the endocavitary route in a patient presenting with a univentricular heart and a Glenn anastomosis].
    Casassus F; Thambo JB; Reuter S; Espil G; Roques X; Dos Santos P; Jimenez M; Clémenty J; Choussat A
    Arch Mal Coeur Vaiss; 2002 May; 95(5):491-4. PubMed ID: 12085751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% should undergo prophylactic implantation of an implantable cardioverter defibrillator.
    Silka MJ; Bar-Cohen Y
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):298-306. PubMed ID: 19808422
    [No Abstract]   [Full Text] [Related]  

  • 27. Lead configuration for defibrillator implantation in a patient with congenital heart disease and a mechanical prosthetic tricuspid valve.
    Leng CT; Crosson JE; Calkins H; Berger RD
    Pacing Clin Electrophysiol; 2001 Aug; 24(8 Pt 1):1291-2. PubMed ID: 11523619
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venoplasty of innominate bridge during implantation of single-chamber ICD in a patient with a persistent left-sided superior vena cava.
    Tauras JM; Palma EC
    Pacing Clin Electrophysiol; 2008 Aug; 31(8):1077-8. PubMed ID: 18684269
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Implantable cardioverter defibrillator lead implantation in patients with a persistent left superior vena cava--feasibility, chances, and limitations: representative cases in adults.
    Guenther M; Kolschmann S; Rauwolf TP; Christoph M; Sandfort V; Strasser RH; Wunderlich C
    Europace; 2013 Feb; 15(2):273-7. PubMed ID: 22997221
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transvenous cardioverter-defibrillator implantation in a patient with tricuspid mechanical prosthesis.
    Biffi M; Bertini M; Ziacchi M; Boriani G
    J Cardiovasc Electrophysiol; 2007 Mar; 18(3):329-31. PubMed ID: 17319002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD? Implantable cardioverter defibrillator implantation guidelines based solely on left ventricular ejection fraction do not apply to adults with congenital heart disease.
    Triedman JK
    Circ Arrhythm Electrophysiol; 2008 Oct; 1(4):307-16; discussion 316. PubMed ID: 19808423
    [No Abstract]   [Full Text] [Related]  

  • 32. The azygos defibrillator lead for elevated defibrillation thresholds: implant technique, lead stability, and patient series.
    Cooper JA; Latacha MP; Soto GE; Garmany RG; Gleva MJ; Chen J; Faddis MN; Smith TW
    Pacing Clin Electrophysiol; 2008 Nov; 31(11):1405-10. PubMed ID: 18950297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Practical aspects of implantable defibrillator therapy in patients with congenital heart disease.
    Walsh EP
    Pacing Clin Electrophysiol; 2008 Feb; 31 Suppl 1():S38-40. PubMed ID: 18226034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Robotic implantation of a multichamber cardiac resynchronization therapy defibrillator.
    Shalaby A; Sharma MS; Zenati MA
    Pacing Clin Electrophysiol; 2006 Aug; 29(8):906-9. PubMed ID: 16923009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prophylactic implantable cardioverter defibrillator placement in a sporadic desmin related myopathy and cardiomyopathy.
    Luethje LG; Boennemann C; Goldfarb L; Goebel HH; Halle M
    Pacing Clin Electrophysiol; 2004 Apr; 27(4):559-60. PubMed ID: 15078418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Supraclavicular vein approach for upgrading an implantable cardioverter defibrillator to a biventricular device.
    Antonelli D; Freedberg NA; Turgeman Y
    Pacing Clin Electrophysiol; 2010 May; 33(5):634-6. PubMed ID: 20025718
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nontraditional placement of an implantable cardioverter-defibrillator in a heterotaxy patient after the completion of total cavopulmonary connection.
    Tsukada T; Hiramatsu Y; Kanemoto S; Lin L; Takahashi-Igari M; Horigome H; Matsushita S; Sakakibara Y
    J Artif Organs; 2013 Dec; 16(4):495-7. PubMed ID: 23728474
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of appropriate defibrillator shock 3 hours and 20 minutes following implantation in a patient with hypertrophic cardiomyopathy.
    Almquist AK; Hanna CA; Haas TS; Maron BJ
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):319-22. PubMed ID: 17764447
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Challenging Lead Implantation Guided by Voltage Map.
    Franco E; Sánchez I; Moreno J
    Rev Esp Cardiol (Engl Ed); 2016 May; 69(5):516. PubMed ID: 26725970
    [No Abstract]   [Full Text] [Related]  

  • 40. Pacemakers and implantable cardioverter-defibrillators in pediatric patients.
    Silka MJ; Bar-Cohen Y
    Heart Rhythm; 2006 Nov; 3(11):1360-6. PubMed ID: 17074646
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.